Global Tuberculosis (TB) Diagnostics Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term 'consumption' came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
According to APO Research, The global Tuberculosis (TB) Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.
APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.
In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.
This report presents an overview of global market for Tuberculosis (TB) Diagnostics, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Tuberculosis (TB) Diagnostics, also provides the value of main regions and countries. Of the upcoming market potential for Tuberculosis (TB) Diagnostics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Tuberculosis (TB) Diagnostics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Tuberculosis (TB) Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global @@@@ company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Descriptive company profiles of the major global players, including Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, Hologic, Qiagen, BioMerieux and Hain Lifescience, etc.
Tuberculosis (TB) Diagnostics segment by Company
1. To analyze and research the global Tuberculosis (TB) Diagnostics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Tuberculosis (TB) Diagnostics key companies, revenue, market share, and recent developments.
3. To split the Tuberculosis (TB) Diagnostics breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Tuberculosis (TB) Diagnostics market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Tuberculosis (TB) Diagnostics significant trends, drivers, influence factors in global and regions.
6. To analyze Tuberculosis (TB) Diagnostics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis (TB) Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tuberculosis (TB) Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis (TB) Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tuberculosis (TB) Diagnostics industry.
Chapter 3: Detailed analysis of Tuberculosis (TB) Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Tuberculosis (TB) Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Tuberculosis (TB) Diagnostics in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
Chapter 9: Concluding Insights.
According to APO Research, The global Tuberculosis (TB) Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.
APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.
In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.
This report presents an overview of global market for Tuberculosis (TB) Diagnostics, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Tuberculosis (TB) Diagnostics, also provides the value of main regions and countries. Of the upcoming market potential for Tuberculosis (TB) Diagnostics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Tuberculosis (TB) Diagnostics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Tuberculosis (TB) Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global @@@@ company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Descriptive company profiles of the major global players, including Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, Hologic, Qiagen, BioMerieux and Hain Lifescience, etc.
Tuberculosis (TB) Diagnostics segment by Company
- Danaher
- Roche
- Thermo Fisher Scientific
- BD
- Abbott
- Hologic
- Qiagen
- BioMerieux
- Hain Lifescience
- Oxford Immunotec
- Culture-Based Diagnostics
- Sputum Smear Microscopy
- Rapid Molecular Diagnostics
- Others
- Diagnostic Laboratories
- Hospitals
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global Tuberculosis (TB) Diagnostics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Tuberculosis (TB) Diagnostics key companies, revenue, market share, and recent developments.
3. To split the Tuberculosis (TB) Diagnostics breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Tuberculosis (TB) Diagnostics market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Tuberculosis (TB) Diagnostics significant trends, drivers, influence factors in global and regions.
6. To analyze Tuberculosis (TB) Diagnostics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis (TB) Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tuberculosis (TB) Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis (TB) Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tuberculosis (TB) Diagnostics industry.
Chapter 3: Detailed analysis of Tuberculosis (TB) Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Tuberculosis (TB) Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Tuberculosis (TB) Diagnostics in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
Chapter 9: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Tuberculosis (TB) Diagnostics Market Size, 2019 VS 2023 VS 2030
1.3 Global Tuberculosis (TB) Diagnostics Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 TUBERCULOSIS (TB) DIAGNOSTICS MARKET DYNAMICS
2.1 Tuberculosis (TB) Diagnostics Industry Trends
2.2 Tuberculosis (TB) Diagnostics Industry Drivers
2.3 Tuberculosis (TB) Diagnostics Industry Opportunities and Challenges
2.4 Tuberculosis (TB) Diagnostics Industry Restraints
3 TUBERCULOSIS (TB) DIAGNOSTICS MARKET BY COMPANY
3.1 Global Tuberculosis (TB) Diagnostics Company Revenue Ranking in 2023
3.2 Global Tuberculosis (TB) Diagnostics Revenue by Company (2019-2024)
3.3 Global Tuberculosis (TB) Diagnostics Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Tuberculosis (TB) Diagnostics Company Manufacturing Base & Headquarters
3.5 Global Tuberculosis (TB) Diagnostics Company, Product Type & Application
3.6 Global Tuberculosis (TB) Diagnostics Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global Tuberculosis (TB) Diagnostics Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 Tuberculosis (TB) Diagnostics Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 TUBERCULOSIS (TB) DIAGNOSTICS MARKET BY TYPE
4.1 Tuberculosis (TB) Diagnostics Type Introduction
4.1.1 Culture-Based Diagnostics
4.1.2 Sputum Smear Microscopy
4.1.3 Rapid Molecular Diagnostics
4.1.4 Others
4.2 Global Tuberculosis (TB) Diagnostics Sales Value by Type
4.2.1 Global Tuberculosis (TB) Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global Tuberculosis (TB) Diagnostics Sales Value by Type (2019-2030)
4.2.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type (2019-2030)
5 TUBERCULOSIS (TB) DIAGNOSTICS MARKET BY APPLICATION
5.1 Tuberculosis (TB) Diagnostics Application Introduction
5.1.1 Diagnostic Laboratories
5.1.2 Hospitals
5.2 Global Tuberculosis (TB) Diagnostics Sales Value by Application
5.2.1 Global Tuberculosis (TB) Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global Tuberculosis (TB) Diagnostics Sales Value by Application (2019-2030)
5.2.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application (2019-2030)
6 TUBERCULOSIS (TB) DIAGNOSTICS MARKET BY REGION
6.1 Global Tuberculosis (TB) Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Tuberculosis (TB) Diagnostics Sales Value by Region (2019-2030)
6.2.1 Global Tuberculosis (TB) Diagnostics Sales Value by Region: 2019-2024
6.2.2 Global Tuberculosis (TB) Diagnostics Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America Tuberculosis (TB) Diagnostics Sales Value (2019-2030)
6.3.2 North America Tuberculosis (TB) Diagnostics Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe Tuberculosis (TB) Diagnostics Sales Value (2019-2030)
6.4.2 Europe Tuberculosis (TB) Diagnostics Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific Tuberculosis (TB) Diagnostics Sales Value (2019-2030)
6.5.2 Asia-Pacific Tuberculosis (TB) Diagnostics Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America Tuberculosis (TB) Diagnostics Sales Value (2019-2030)
6.6.2 Latin America Tuberculosis (TB) Diagnostics Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa Tuberculosis (TB) Diagnostics Sales Value (2019-2030)
6.7.2 Middle East & Africa Tuberculosis (TB) Diagnostics Sales Value Share by Country, 2023 VS 2030
7 TUBERCULOSIS (TB) DIAGNOSTICS MARKET BY COUNTRY
7.1 Global Tuberculosis (TB) Diagnostics Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Tuberculosis (TB) Diagnostics Sales Value by Country (2019-2030)
7.2.1 Global Tuberculosis (TB) Diagnostics Sales Value by Country (2019-2024)
7.2.2 Global Tuberculosis (TB) Diagnostics Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.3.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.3.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.4.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.4.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.5.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.6.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.7.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.8.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.9.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.10.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.11.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.12.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.13.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.14.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.15.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.16.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.17.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.18.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.19.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.20.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.21.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Danaher
8.1.1 Danaher Comapny Information
8.1.2 Danaher Business Overview
8.1.3 Danaher Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2019-2024)
8.1.4 Danaher Tuberculosis (TB) Diagnostics Product Portfolio
8.1.5 Danaher Recent Developments
8.2 Roche
8.2.1 Roche Comapny Information
8.2.2 Roche Business Overview
8.2.3 Roche Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2019-2024)
8.2.4 Roche Tuberculosis (TB) Diagnostics Product Portfolio
8.2.5 Roche Recent Developments
8.3 Thermo Fisher Scientific
8.3.1 Thermo Fisher Scientific Comapny Information
8.3.2 Thermo Fisher Scientific Business Overview
8.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2019-2024)
8.3.4 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Portfolio
8.3.5 Thermo Fisher Scientific Recent Developments
8.4 BD
8.4.1 BD Comapny Information
8.4.2 BD Business Overview
8.4.3 BD Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2019-2024)
8.4.4 BD Tuberculosis (TB) Diagnostics Product Portfolio
8.4.5 BD Recent Developments
8.5 Abbott
8.5.1 Abbott Comapny Information
8.5.2 Abbott Business Overview
8.5.3 Abbott Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2019-2024)
8.5.4 Abbott Tuberculosis (TB) Diagnostics Product Portfolio
8.5.5 Abbott Recent Developments
8.6 Hologic
8.6.1 Hologic Comapny Information
8.6.2 Hologic Business Overview
8.6.3 Hologic Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2019-2024)
8.6.4 Hologic Tuberculosis (TB) Diagnostics Product Portfolio
8.6.5 Hologic Recent Developments
8.7 Qiagen
8.7.1 Qiagen Comapny Information
8.7.2 Qiagen Business Overview
8.7.3 Qiagen Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2019-2024)
8.7.4 Qiagen Tuberculosis (TB) Diagnostics Product Portfolio
8.7.5 Qiagen Recent Developments
8.8 BioMerieux
8.8.1 BioMerieux Comapny Information
8.8.2 BioMerieux Business Overview
8.8.3 BioMerieux Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2019-2024)
8.8.4 BioMerieux Tuberculosis (TB) Diagnostics Product Portfolio
8.8.5 BioMerieux Recent Developments
8.9 Hain Lifescience
8.9.1 Hain Lifescience Comapny Information
8.9.2 Hain Lifescience Business Overview
8.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2019-2024)
8.9.4 Hain Lifescience Tuberculosis (TB) Diagnostics Product Portfolio
8.9.5 Hain Lifescience Recent Developments
8.10 Oxford Immunotec
8.10.1 Oxford Immunotec Comapny Information
8.10.2 Oxford Immunotec Business Overview
8.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2019-2024)
8.10.4 Oxford Immunotec Tuberculosis (TB) Diagnostics Product Portfolio
8.10.5 Oxford Immunotec Recent Developments
9 CONCLUDING INSIGHTS
10 APPENDIX
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
10.6 Disclaimer
1.1 Product Definition
1.2 Global Tuberculosis (TB) Diagnostics Market Size, 2019 VS 2023 VS 2030
1.3 Global Tuberculosis (TB) Diagnostics Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 TUBERCULOSIS (TB) DIAGNOSTICS MARKET DYNAMICS
2.1 Tuberculosis (TB) Diagnostics Industry Trends
2.2 Tuberculosis (TB) Diagnostics Industry Drivers
2.3 Tuberculosis (TB) Diagnostics Industry Opportunities and Challenges
2.4 Tuberculosis (TB) Diagnostics Industry Restraints
3 TUBERCULOSIS (TB) DIAGNOSTICS MARKET BY COMPANY
3.1 Global Tuberculosis (TB) Diagnostics Company Revenue Ranking in 2023
3.2 Global Tuberculosis (TB) Diagnostics Revenue by Company (2019-2024)
3.3 Global Tuberculosis (TB) Diagnostics Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Tuberculosis (TB) Diagnostics Company Manufacturing Base & Headquarters
3.5 Global Tuberculosis (TB) Diagnostics Company, Product Type & Application
3.6 Global Tuberculosis (TB) Diagnostics Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global Tuberculosis (TB) Diagnostics Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 Tuberculosis (TB) Diagnostics Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 TUBERCULOSIS (TB) DIAGNOSTICS MARKET BY TYPE
4.1 Tuberculosis (TB) Diagnostics Type Introduction
4.1.1 Culture-Based Diagnostics
4.1.2 Sputum Smear Microscopy
4.1.3 Rapid Molecular Diagnostics
4.1.4 Others
4.2 Global Tuberculosis (TB) Diagnostics Sales Value by Type
4.2.1 Global Tuberculosis (TB) Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global Tuberculosis (TB) Diagnostics Sales Value by Type (2019-2030)
4.2.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type (2019-2030)
5 TUBERCULOSIS (TB) DIAGNOSTICS MARKET BY APPLICATION
5.1 Tuberculosis (TB) Diagnostics Application Introduction
5.1.1 Diagnostic Laboratories
5.1.2 Hospitals
5.2 Global Tuberculosis (TB) Diagnostics Sales Value by Application
5.2.1 Global Tuberculosis (TB) Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global Tuberculosis (TB) Diagnostics Sales Value by Application (2019-2030)
5.2.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application (2019-2030)
6 TUBERCULOSIS (TB) DIAGNOSTICS MARKET BY REGION
6.1 Global Tuberculosis (TB) Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Tuberculosis (TB) Diagnostics Sales Value by Region (2019-2030)
6.2.1 Global Tuberculosis (TB) Diagnostics Sales Value by Region: 2019-2024
6.2.2 Global Tuberculosis (TB) Diagnostics Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America Tuberculosis (TB) Diagnostics Sales Value (2019-2030)
6.3.2 North America Tuberculosis (TB) Diagnostics Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe Tuberculosis (TB) Diagnostics Sales Value (2019-2030)
6.4.2 Europe Tuberculosis (TB) Diagnostics Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific Tuberculosis (TB) Diagnostics Sales Value (2019-2030)
6.5.2 Asia-Pacific Tuberculosis (TB) Diagnostics Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America Tuberculosis (TB) Diagnostics Sales Value (2019-2030)
6.6.2 Latin America Tuberculosis (TB) Diagnostics Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa Tuberculosis (TB) Diagnostics Sales Value (2019-2030)
6.7.2 Middle East & Africa Tuberculosis (TB) Diagnostics Sales Value Share by Country, 2023 VS 2030
7 TUBERCULOSIS (TB) DIAGNOSTICS MARKET BY COUNTRY
7.1 Global Tuberculosis (TB) Diagnostics Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Tuberculosis (TB) Diagnostics Sales Value by Country (2019-2030)
7.2.1 Global Tuberculosis (TB) Diagnostics Sales Value by Country (2019-2024)
7.2.2 Global Tuberculosis (TB) Diagnostics Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.3.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.3.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.4.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.4.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.5.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.6.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.7.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.8.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.9.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.10.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.11.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.12.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.13.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.14.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.15.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.16.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.17.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.18.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.19.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.20.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global Tuberculosis (TB) Diagnostics Sales Value Growth Rate (2019-2030)
7.21.2 Global Tuberculosis (TB) Diagnostics Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Tuberculosis (TB) Diagnostics Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Danaher
8.1.1 Danaher Comapny Information
8.1.2 Danaher Business Overview
8.1.3 Danaher Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2019-2024)
8.1.4 Danaher Tuberculosis (TB) Diagnostics Product Portfolio
8.1.5 Danaher Recent Developments
8.2 Roche
8.2.1 Roche Comapny Information
8.2.2 Roche Business Overview
8.2.3 Roche Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2019-2024)
8.2.4 Roche Tuberculosis (TB) Diagnostics Product Portfolio
8.2.5 Roche Recent Developments
8.3 Thermo Fisher Scientific
8.3.1 Thermo Fisher Scientific Comapny Information
8.3.2 Thermo Fisher Scientific Business Overview
8.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2019-2024)
8.3.4 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Portfolio
8.3.5 Thermo Fisher Scientific Recent Developments
8.4 BD
8.4.1 BD Comapny Information
8.4.2 BD Business Overview
8.4.3 BD Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2019-2024)
8.4.4 BD Tuberculosis (TB) Diagnostics Product Portfolio
8.4.5 BD Recent Developments
8.5 Abbott
8.5.1 Abbott Comapny Information
8.5.2 Abbott Business Overview
8.5.3 Abbott Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2019-2024)
8.5.4 Abbott Tuberculosis (TB) Diagnostics Product Portfolio
8.5.5 Abbott Recent Developments
8.6 Hologic
8.6.1 Hologic Comapny Information
8.6.2 Hologic Business Overview
8.6.3 Hologic Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2019-2024)
8.6.4 Hologic Tuberculosis (TB) Diagnostics Product Portfolio
8.6.5 Hologic Recent Developments
8.7 Qiagen
8.7.1 Qiagen Comapny Information
8.7.2 Qiagen Business Overview
8.7.3 Qiagen Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2019-2024)
8.7.4 Qiagen Tuberculosis (TB) Diagnostics Product Portfolio
8.7.5 Qiagen Recent Developments
8.8 BioMerieux
8.8.1 BioMerieux Comapny Information
8.8.2 BioMerieux Business Overview
8.8.3 BioMerieux Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2019-2024)
8.8.4 BioMerieux Tuberculosis (TB) Diagnostics Product Portfolio
8.8.5 BioMerieux Recent Developments
8.9 Hain Lifescience
8.9.1 Hain Lifescience Comapny Information
8.9.2 Hain Lifescience Business Overview
8.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2019-2024)
8.9.4 Hain Lifescience Tuberculosis (TB) Diagnostics Product Portfolio
8.9.5 Hain Lifescience Recent Developments
8.10 Oxford Immunotec
8.10.1 Oxford Immunotec Comapny Information
8.10.2 Oxford Immunotec Business Overview
8.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2019-2024)
8.10.4 Oxford Immunotec Tuberculosis (TB) Diagnostics Product Portfolio
8.10.5 Oxford Immunotec Recent Developments
9 CONCLUDING INSIGHTS
10 APPENDIX
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
10.6 Disclaimer
